You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

SUCCINYLCHOLINE CHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for succinylcholine chloride and what is the scope of freedom to operate?

Succinylcholine chloride is the generic ingredient in five branded drugs marketed by Sandoz, Hospira, Accord Hlthcare, Adaptis, Amneal, Amphastar Pharms Inc, Amring Pharms, Aspiro, Baxter Hlthcare Corp, Be Pharms, Breckenridge, Deva Holding As, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Intl Medication, Mankind Pharma, Meitheal, Micro Labs, Nexus, Organon Usa Inc, Sagent Pharms Inc, Somerset Theraps Llc, Umedica, Zydus Pharms, Apothecon, and Steriscience, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for succinylcholine chloride. Twenty-nine suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for SUCCINYLCHOLINE CHLORIDE
Drug Prices for SUCCINYLCHOLINE CHLORIDE

See drug prices for SUCCINYLCHOLINE CHLORIDE

Recent Clinical Trials for SUCCINYLCHOLINE CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rutgers, The State University of New JerseyN/A
Avera PharmaceuticalsPhase 1/Phase 2

See all SUCCINYLCHOLINE CHLORIDE clinical trials

Generic filers with tentative approvals for SUCCINYLCHOLINE CHLORIDE
Applicant Application No. Strength Dosage Form
⤷  Sign Up⤷  Sign Up100MG/5ML (20MG/ML)SOLUTION;INTRAMUSCULAR, INTRAVENOUS

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for SUCCINYLCHOLINE CHLORIDE
Medical Subject Heading (MeSH) Categories for SUCCINYLCHOLINE CHLORIDE

US Patents and Regulatory Information for SUCCINYLCHOLINE CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Breckenridge SUCCINYLCHOLINE CHLORIDE succinylcholine chloride INJECTABLE;INJECTION 212638-001 Oct 9, 2019 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira QUELICIN PRESERVATIVE FREE succinylcholine chloride INJECTABLE;INJECTION 008845-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Meitheal SUCCINYLCHOLINE CHLORIDE succinylcholine chloride INJECTABLE;INJECTION 214514-001 Oct 19, 2021 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz ANECTINE succinylcholine chloride INJECTABLE;INJECTION 008453-002 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Intl Medication SUCCINYLCHOLINE CHLORIDE succinylcholine chloride INJECTABLE;INJECTION 085400-001 Feb 4, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.